Hypoxia-Inducible Factors Activate CD133 Promoter through ETS Family Transcription Factors
Open Access
- 20 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6), e66255
- https://doi.org/10.1371/journal.pone.0066255
Abstract
CD133 is a cellular surface protein that has been reported to be a cancer stem cell marker, and thus it is considered to be a potential target for cancer treatment. However, the mechanism regulating CD133 expression is not yet understood. In this study, we analyzed the activity of five putative promoters (P1–P5) of CD133 in human embryonic kidney (HEK) 293 cells and colon cancer cell line WiDr, and found that the activity of promoters, particularly of P5, is elevated by overexpression of hypoxia-inducible factors (HIF-1α and HIF-2α). Deletion and mutation analysis identified one of the two E-twenty six (ETS) binding sites (EBSs) in the P5 region as being essential for its promoter activity induced by HIF-1α and HIF-2α. In addition, a chromatin imunoprecipitation assay demonstrated that HIF-1α and HIF-2α bind to the proximal P5 promoter at the EBSs. The immunoprecipitation assay showed that HIF-1α physically interacts with Elk1; however, HIF-2α did not bind to Elk1 or ETS1. Furthermore, knockdown of both HIF-1α and HIF-2α resulted in a reduction of CD133 expression in WiDr. Taken together, our results revealed that HIF-1α and HIF-2α activate CD133 promoter through ETS proteins.This publication has 36 references indexed in Scilit:
- Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancerBreast Cancer Research, 2012
- Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signalingNucleic Acids Research, 2011
- Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2International Journal of Oncology, 2011
- HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal CancersThe American Journal of Pathology, 2010
- Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarksMolecular Cancer, 2010
- Hypoxia inducible factors in cancer stem cellsBritish Journal of Cancer, 2010
- Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosisBritish Journal of Cancer, 2009
- Abnormal DNA Methylation ofCD133in Colorectal and Glioblastoma TumorsCancer Research, 2008
- CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityInternational Journal of Cancer, 2007
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002